- Slice of Manufacturing
- Posts
- Eli Lilly Announces $1 Billion Limerick Expansion, $800 Million Kinsale Facility
Eli Lilly Announces $1 Billion Limerick Expansion, $800 Million Kinsale Facility
Slice of Manufacturing Team
September 16, 2024
Key Highlights:
$1 billion expansion of Limerick site to increase Alzheimer's drug production.
$800 million expansion of Kinsale facility for diabetes and obesity treatments.
Limerick will create 150 new jobs, with production set to begin in 2026.
Advanced technologies like AI and robotics to ensure efficient operations.
Sustainability initiatives include solar power and reduced energy use.
Source: PR Newswire
Notable Quotes:
“These investments will boost the production of some of our medicines, helping millions of people with diabetes, obesity and Alzheimer's disease live the healthiest lives possible.”
“Alzheimer's disease is a devastating diagnosis for both the patient and their loved ones, along with having a huge burden on society.”
Our Take:
Eli Lilly's recent $1 billion investment in its Limerick site underscores the company's commitment to addressing some of the world's most pressing health challenges, particularly in Alzheimer's disease. This expansion, paired with their $800 million Kinsale facility, reinforces Lilly's strategic focus on biologics and cutting-edge treatments. Leveraging advanced technologies like AI and robotics, along with strong sustainability initiatives, positions Lilly as a forward-thinking leader in pharmaceutical manufacturing. These investments will not only advance healthcare innovation but also create high-skilled jobs in Ireland, marking a significant economic boost for the region.